Genprex Inc GNPX 深 滬
已收盤 01-30 16:00:00 美东时间
2.66
+0.200
+8.13%
華盛通- 最 高2.85
- 今 開2.65
- 成交量 196.50万股
- 最 低 2.54
- 昨 收 2.46
- 總市值 603.90万
- 52周最高 55.00
- 市盈率 靜 --
- 換手率 86.55%
- 52周最低 1.71
- 委 比 -18.70%
- 總股本 227.03万
- 歷史最高 38900.00
- 量 比 1.11
- 振 幅 12.60%
- 歷史最低 1.71
- 每 手 1
- 風險率 6.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Friday's After-Market Session
Gainers MoonLake (NASDAQ:MLTX) stock rose 8.2% to $20.0 during Friday's after-...
01-10 05:05
Genprex Announces Preliminary in Vivo Preclinical Proof-of-concept Data for GPX-002 Diabetes Gene Therapy Drug Candidate, in a Non-human Primate Model and Mouse Model of Type 2 Diabetes
Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human PrimatesGPX-002 Rejuvenated Exhausted Beta Cells and Normalized Glucose Levels in Type 2
01-06 20:04
Genprex Expands Lung Cancer Trials with New Ohio Site to Accelerate Patient Enrollment
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ:GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today
2025-11-19 20:07
Genprex Secures U.S. Patent for Reqorsa® Therapy
Genprex ( ($GNPX) ) has provided an update. On November 18, 2025, Genprex annou...
2025-11-18 20:27
Genprex Announces $10M ATM Registered Direct Offering Of 377,780 Shares Of Common Stock At $9.00 Per Share
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has
2025-10-28 23:25
Genprex Announces Securities Purchase Agreement and Offering
The latest update is out from Genprex ( ($GNPX) ). On October 23, 2025, Genprex...
2025-10-24 20:48
Genprex launches offering to raise up to $8.1M
Genprex (NASDAQ:GNPX) has announced a registered direct offering of 243,622 shares of common stock at $11.21 per share, priced at-the-market under Nasdaq rules. In a concurrent private placement, the ...
2025-10-23 20:21
Genprex Announces Positive Preclinical Data on Reqorsa
Genprex ( ($GNPX) ) has provided an announcement. On October 23, 2025, Genprex ...
2025-10-23 19:29
Genprex Implements Previously Disclosed 1-For-50 Reverse Stock Split, Reducing Outstanding Shares To 1,004,326
As of 12:01 a.m. on October 21, 2025, Genprex, Inc., a Delaware corporation (the "Company"), effected the previously disclosed one-for-fifty (1:50) reverse stock split (the "Reverse Stock Split") of the Company's issued
2025-10-21 23:04
Genprex Announces Reverse Stock Split Amendment
An update from Genprex ( ($GNPX) ) is now available. On October 16, 2025, Genpr...
2025-10-17 21:29
